Emergent BioSolutions to Participate in Upcoming Investor Conferences
Emergent BioSolutions (NYSE: EBS) has announced its participation in multiple upcoming investor conferences in May and June 2025. The company's executive management team will attend:
- RBC Global Healthcare Conference in New York (May 20) featuring a fireside chat at 3:35 pm ET
- Goldman Sachs Leveraged Finance Conference in Dana Point, California (May 29)
- Benchmark's 5th Annual Healthcare House Call Virtual Investor Conference (May 29)
- Jefferies Global Healthcare Conference in New York (June 5) with a presentation at 1:25 pm ET
Virtual attendance options are available for select events, and presentation replays will be accessible through Emergent's website investor page.
Emergent BioSolutions (NYSE: EBS) ha annunciato la sua partecipazione a diverse conferenze per investitori previste per maggio e giugno 2025. Il team di gestione esecutiva dell'azienda sar脿 presente a:
- RBC Global Healthcare Conference a New York (20 maggio) con una conversazione informale alle 15:35 ET
- Goldman Sachs Leveraged Finance Conference a Dana Point, California (29 maggio)
- Benchmark's 5th Annual Healthcare House Call Virtual Investor Conference (29 maggio)
- Jefferies Global Healthcare Conference a New York (5 giugno) con una presentazione alle 13:25 ET
Per alcuni eventi 猫 disponibile la partecipazione virtuale, e le registrazioni delle presentazioni saranno accessibili tramite la pagina investitori del sito web di Emergent.
Emergent BioSolutions (NYSE: EBS) ha anunciado su participaci贸n en varias conferencias para inversores que se celebrar谩n en mayo y junio de 2025. El equipo ejecutivo de la compa帽铆a asistir谩 a:
- RBC Global Healthcare Conference en Nueva York (20 de mayo) con una charla informal a las 3:35 pm ET
- Goldman Sachs Leveraged Finance Conference en Dana Point, California (29 de mayo)
- Benchmark's 5th Annual Healthcare House Call Virtual Investor Conference (29 de mayo)
- Jefferies Global Healthcare Conference en Nueva York (5 de junio) con una presentaci贸n a la 1:25 pm ET
Habr谩 opciones de asistencia virtual para algunos eventos, y las repeticiones de las presentaciones estar谩n disponibles en la p谩gina de inversores del sitio web de Emergent.
Emergent BioSolutions (NYSE: EBS)電� 2025雲� 5鞗旉臣 6鞗旍棎 鞓堨爼霅� 鞐煬 韴瀽鞛� 旎嵓霟办姢鞐� 彀胳棳頃� 瓴冹澊霛缄碃 氚滍憸頄堨姷雼堧嫟. 須岇偓鞚� 瓴届榿歆勳潃 雼れ潓 頄夓偓鞐� 彀胳劃頃� 鞓堨爼鞛呺媹雼�:
- RBC 旮�搿滊矊 項姢旒�鞏� 旎嵓霟办姢 雺挫殨 (5鞗� 20鞚�) 鞓ろ泟 3鞁� 35攵� ET鞐� 韺岇澊鞏挫偓鞚措摐 毂勴寘
- 瓿摐毵� 靷姢 霠堧矂毽霌� 韺岇澊雮胳姢 旎嵓霟办姢 旌橂Μ韽媹鞎� 雼る倶韽澑韸� (5鞗� 29鞚�)
- Benchmark's 5th Annual Healthcare House Call Virtual Investor Conference (5鞗� 29鞚�)
- 鞝滍嵓毽姢 旮�搿滊矊 項姢旒�鞏� 旎嵓霟办姢 雺挫殨 (6鞗� 5鞚�) 鞓ろ泟 1鞁� 25攵� ET鞐� 氚滍憸
鞚茧秬 頄夓偓鞐愲姅 臧�靸� 彀胳劃 鞓奠厴鞚� 鞝滉车霅橂┌, 氚滍憸 雲鬼檾電� Emergent 鞗轨偓鞚错姼 韴瀽鞛� 韼橃澊歆�鞐愳劀 鞁滌箔頃� 靾� 鞛堨姷雼堧嫟.
Emergent BioSolutions (NYSE : EBS) a annonc茅 sa participation 脿 plusieurs conf茅rences pour investisseurs pr茅vues en mai et juin 2025. L'茅quipe de direction de la soci茅t茅 assistera 脿 :
- RBC Global Healthcare Conference 脿 New York (20 mai) avec une discussion informelle 脿 15h35 ET
- Goldman Sachs Leveraged Finance Conference 脿 Dana Point, Californie (29 mai)
- Benchmark's 5th Annual Healthcare House Call Virtual Investor Conference (29 mai)
- Jefferies Global Healthcare Conference 脿 New York (5 juin) avec une pr茅sentation 脿 13h25 ET
Des options de participation virtuelle sont disponibles pour certains 茅v茅nements, et les rediffusions des pr茅sentations seront accessibles via la page investisseurs du site web d鈥橢mergent.
Emergent BioSolutions (NYSE: EBS) hat seine Teilnahme an mehreren bevorstehenden Investorenkonferenzen im Mai und Juni 2025 angek眉ndigt. Das F眉hrungsteam des Unternehmens wird an folgenden Veranstaltungen teilnehmen:
- RBC Global Healthcare Conference in New York (20. Mai) mit einem Fireside-Chat um 15:35 Uhr ET
- Goldman Sachs Leveraged Finance Conference in Dana Point, Kalifornien (29. Mai)
- Benchmark's 5th Annual Healthcare House Call Virtual Investor Conference (29. Mai)
- Jefferies Global Healthcare Conference in New York (5. Juni) mit einer Pr盲sentation um 13:25 Uhr ET
F眉r ausgew盲hlte Veranstaltungen stehen virtuelle Teilnahmeoptionen zur Verf眉gung, und Pr盲sentationsaufzeichnungen werden auf der Investorenseite der Emergent-Website zug盲nglich sein.
- None.
- None.
GAITHERSBURG, Md., May 14, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of its executive management team will participate in the following investor conferences:
- RBC Global Healthcare Conference (New York, New York)
Fireside chat on Tuesday, May 20 at 3:35 pm ET
Virtual attendees can participate via听
- Goldman Sachs Leveraged Finance Conference, May 29, 2025 (Dana Point, California)
- Benchmark鈥檚 5th Annual Healthcare House Call Virtual Investor Conference
Presentation on Thursday, May 29
- Jefferies Global Healthcare Conference (New York, New York)
Presentation on Thursday, June 5 at 1:25 pm ET
Virtual attendees can participate via听
A replay of the presentations can be accessed from the page of Emergent鈥檚 website.
About Emergent BioSolutions听
At Emergent, our mission is to protect and save lives. For over 25 years, we鈥檝e been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today鈥檚 health challenges and tomorrow鈥檚 threats, visit our听听and follow us on听,听,听,听听and听.鈥�
Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
Media Contact:
Assal Hellmer
Vice President, Communications
听
FAQ
Which investor conferences will Emergent BioSolutions (EBS) attend in May-June 2025?
When is Emergent BioSolutions' (EBS) presentation at the RBC Global Healthcare Conference 2025?
How can investors access Emergent BioSolutions' (EBS) conference presentations?
What time is Emergent BioSolutions' (EBS) presentation at the Jefferies Global Healthcare Conference 2025?
